- The report assesses Allergic Asthma therapeutics based on drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Allergic Asthma
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain
competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Allergic Asthma
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Allergic Asthma pipeline depth and focus of
Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most
attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove
them from pipeline
Buy a Sample copy of This Report @ http://www.radiantinsights.com/research/allergic-asthma-pipeline-reviewh2-2016/request-sample
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Allergic Asthma Overview 8
Therapeutics Development 9
Pipeline Products for Allergic Asthma - Overview 9
Pipeline Products for Allergic Asthma - Comparative Analysis 10
Allergic Asthma - Therapeutics under Development by Companies 11
Allergic Asthma - Therapeutics under Investigation by Universities/Institutes 14
Allergic Asthma - Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Allergic Asthma - Products under Development by Companies 18
Allergic Asthma - Products under Investigation by Universities/Institutes 21
Allergic Asthma - Companies Involved in Therapeutics Development 22
ALK-Abello A/S 22
Allergopharma GmbH & Co. KG 23
Amgen Inc. 24
Aquinox Pharmaceuticals Inc. 25
ASIT biotech s.a. 26
Aslan Pharmaceuticals Pte. Ltd. 27
Chiesi Farmaceutici SpA 28
Circassia Pharmaceuticals Plc 29
CSL Limited 30